Glycogen storage disease type 1a (von Gierke disease, GSD-1A) is caused by the deficiency of microsomal glucose-6-phosphatase (G6Pase) activity which catalyzes the final common step of ...

A new study from scientists at the Buck Institute for Research on Aging has revealed a surprising player in the battle ...

A new study from scientists at the Buck Institute for Research on Aging has revealed a surprising player in the battle ...

Scientists have uncovered a surprising sugar-related mechanism inside brain cells that could transform how we fight Alzheimer ...

Researchers have uncovered how the breakdown of glycogen may protect the brain from neurodegeneration and Alzheimer's.

Scientists found that brain cells can tap a hidden sugar stash to clean up the toxic proteins behind Alzheimer’s. By kick-starting an enzyme called GlyP, they reroute stored sugar into a protective ...

Preterm birth can be severely harmful to neonates. Currently, no effective clinical treatments target in utero inflammation ...

A series of amidine, thiourea, and guanidine derivatives of 2-amino-6-(trifluoromethoxy)benzothiazole termed 2, 3, and 4, respectively, and structurally related to riluzole, a neuroprotective drug in ...

Tunable emission carbonized polymer dots (CPDs) are highly desirable for the preparation of optoelectronic devices, especially white light-emitting diodes (WLEDs). In most available studies, ...